1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Esketamine
Trade Name:
Spravato
Manufacturer/Distributor:
Janssen Inc.
Classification:
Antidepressant
ATC Class:
N06AX27 - esketamine
Status:
active
Notice of Compliance (yyyy/mm/dd):
2020/05/19
Date Marketed in Canada (yyyy/mm/dd):
2020/05/20
Presentation:
Nasal spray: 28 mg. DIN: 02499290
Comments:
Indicated in combination with a SSRI or SNRI, for the treatment of major depressive disorder in adults who have not responded adequately to at least two separate courses of treatment with different antidepressants, each given at adequate doses and duration of therapy. Medication can only be prescribed by physicians enrolled in Janssen Journey Program. It is administered under the direct supervision of a HCP and patients are monitored by a HCP after the dose is given.
Back to:
Drug Product Listings 
